Canada extends GMP to cover active pharmaceutical ingredients

05/14/2013 | In-PharmaTechnologist.com

Canada has issued new regulations, effective in November, that will establish good manufacturing practice requirements for all companies that manufacture, package/label, test or import APIs. Labeling will need to ensure that APIs can be traced from the original manufacturer to the maker of the drug in dosage form.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY